Of the CD34−CD10+CD19+CD179a+ population, the number of lymphoid cells in the common ALL BCR/ABL+ patients (mean: 5.7 subpopulations/patient) was reduced compared to the BCR/ABL− patients (mean: 9.5 subpopulations/patient). This evidence concerns the gene VPREB1 and acute lymphoblastic leukemia.